Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-697
Closed -$45.4K 2052
2025
Q4
$45.4K Buy
697
+133
+24% +$10.6K ﹤0.01% 1650
2025
Q3
$46.3K Sell
564
-26,371
-98% -$1.9M ﹤0.01% 1682
2025
Q2
$1.77M Sell
26,935
-19,289
-42% -$1.2M ﹤0.01% 973
2025
Q1
$3.03M Sell
46,224
-109,870
-70% -$7.44M 0.01% 836
2024
Q4
$12M Buy
156,094
+91,430
+141% +$7.9M 0.03% 517
2024
Q3
$5.4M Buy
64,664
+58,931
+1,028% +$3.92M 0.01% 699
2024
Q2
$316K Sell
5,733
-225,928
-98% -$12.3M ﹤0.01% 1404
2024
Q1
$16.1M Buy
231,661
+17,062
+8% +$1.08M 0.04% 459
2023
Q4
$11.9M Buy
214,599
+143,212
+201% +$6.46M 0.03% 522
2023
Q3
$2.56M Sell
71,387
-93,284
-57% -$3.22M 0.01% 860
2023
Q2
$5.21M Buy
164,671
+153,922
+1,432% +$5.88M 0.01% 680
2023
Q1
$331K Buy
10,749
+10,745
+268,625% +$326K ﹤0.01% 1503
2022
Q4
$124 Buy
+4
New +$92 ﹤0.01% 2128

Other funds holding ACLX

Federated Hermes's ACLX Position: Q1 2026 in Review

Federated Hermes sold out of Arcellx (ACLX) in Q1 2026, closing a stake of 697 shares — an estimated $45.4K sold.

Federated Hermes first reported a position in ACLX in Q4 2022 and held it in 13 quarters. The position peaked at $16.1M in Q1 2024. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Federated Hermes reported no remaining Arcellx position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 697 Arcellx shares in Q1 2026, an estimated $45.4K.
  • Federated Hermes first reported a position in Arcellx in Q4 2022 and held it in 13 quarters.
  • Federated Hermes's Arcellx position peaked at $16.1M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.